RASSF1A Promoter Methylation and Kras2 Mutations in Non Small Cell Lung Cancer

This publication has 25 references indexed in Scilit:

• Cell Signaling: Life or Death Decisions of Ras Proteins
  Current Biology, 2002
• Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
  2002
• Identification of a Novel Ras-Regulated Proapoptotic Pathway
  Current Biology, 2002
• Hypermethylation of the CpG island of theRASSF1A gene in ovarian and renal cell carcinomas
  International Journal of Cancer, 2001
• Wildtype Kras2 can inhibit lung carcinogenesis in mice
  Nature Genetics, 2001
• The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas
  Oncogene, 2001
• Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
  JNCI Journal of the National Cancer Institute, 2001
• Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
  Oncogene, 2001
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
  Nature Genetics, 2000
• Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.
  1995